Syndecan-Fc Hybrid Molecule as a PotentIn VitroMicrobicidal Anti-HIV-1 Agent
- 1 July 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (7) , 2753-2766
Abstract
In the absence of a vaccine, there is an urgent need for the development of safe and effective topical microbicides to prevent the sexual transmission of human immunodeficiency virus type 1 (HIV-1). In this study, we proposed to develop a novel class of microbicides using syndecan as the antiviral agent. Specifically, we generated a soluble syndecan-Fc hybrid molecule by fusing the ectodomain of syndecan-1 to the Fc domain of a human IgG. We then tested the syndecan-Fc hybrid molecule for variousin vitromicrobicidal anti-HIV-1 properties. Remarkably, the syndecan-Fc hybrid molecule possesses multiple attractive microbicidal properties: (i) it blocks HIV-1 infection of primary targets including T cells, macrophages, and dendritic cells (DC); (ii) it exhibits a broad range of antiviral activity against primary HIV-1 isolates, multidrug resistant HIV-1 isolates, HIV-2, and simian immunodeficiency virus (SIV); (iii) it prevents transmigration of HIV-1 through human primary genital epithelial cells; (iv) it prevents HIV-1 transfer from dendritic cells to CD4+T cells; (v) it is potent when added 2 h prior to addition of HIV-1 to target cells; (vi) it is potent at a low pH; (vii) it blocks HIV-1 infectivity when diluted in genital fluids; and (viii) it prevents herpes simplex virus infection. The heparan sulfate chains of the syndecan-Fc hybrid molecule are absolutely required for HIV-1 neutralization. Several lines of evidence suggest that the highly conserved Arg298 in the V3 region of gp120 serves as the locus for the syndecan-Fc hybrid molecule neutralization. In conclusion, this study suggests that the syndecan-Fc hybrid molecule represents the prototype of a new generation of microbicidal agents that may have promise for HIV-1 prevention.Keywords
This publication has 46 references indexed in Scilit:
- Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virusProceedings of the National Academy of Sciences, 2008
- Cost-effective production of a vaginal protein microbicide to prevent HIV transmissionProceedings of the National Academy of Sciences, 2008
- Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1Proceedings of the National Academy of Sciences, 2007
- Multiple Receptor Interactions Trigger Release of Membrane and Intracellular Calcium Stores Critical for Herpes Simplex Virus EntryMolecular Biology of the Cell, 2007
- Cell-Free Human Immunodeficiency Virus Type 1 Transcytosis through Primary Genital Epithelial CellsJournal of Virology, 2007
- Which Topical Microbicides for Blocking HIV-1 Transmission Will Work in the Real World?PLOS Medicine, 2006
- Constitutive and Accelerated Shedding of Murine Syndecan-1 Is Mediated by Cleavage of Its Core Protein at a Specific Juxtamembrane SiteBiochemistry, 2005
- Contribution of Proteoglycans to Human Immunodeficiency Virus Type 1 Brain InvasionJournal of Virology, 2004
- Syndecans and HIV-1 pathogenesisMicrobes and Infection, 2004
- Binding of Recombinant Feline Immunodeficiency Virus Surface Glycoprotein to Feline Cells: Role of CXCR4, Cell-Surface Heparans, and an Unidentified Non-CXCR4 ReceptorJournal of Virology, 2001